Apellis has been acquired by Biogen.

Please visit www.biogen.com for more information.

Courageous
Science +
Compassion

Leading the way in complement science for patients
Read the latest news from Apellis

Our Pipeline We aim to transform treatment across a broad range
of debilitating diseases driven by complement »

We Replace
Impossible with How

We challenge conventional thinking and always question if there's a better way.

Join the Team